found that ovarian cancer-derived EVs carry NID1 through ERK/MAPK to promote EMT, accelerate angiogenesis, and promote tumor invasion (155), but the role of NID1 in HCC is still unclear (156). Here, NID1 is linked to hepatocellular carcinoma.